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ABSTRACT Peripheral and hepatic-portal plasma levels of neurotensin (NT) in fed and fasted chickens were
determined using RIA. Portal levels of NT1–13 (fed =
61.3 ± 3.9 fmol/mL; fasted = 44.5 ± 3.9 fmol/mL)
were significantly higher than peripheral levels (fed =
8.2 ± 3.3 fmol/mL; fasted = 7.8 ± 3.0 fmol/mL) collected from the wing vein, indicating that some NT is
metabolized in the liver. Portal plasma levels of NT
collected from fed birds were also significantly higher
than portal plasma levels of NT collected from fasted
birds. Neurotensin, as identified by HPLC, exhibited a
2-fold increase in plasma extracts following perfusion of
the proximal ileum with a 10-mg sample of oleic acid,
as compared with control samples of plasma collected

before oleic acid perfusion. In whole-animal studies, the
injection of a micellar solution of oleic acid into isolated
segments of the duodenum resulted in elevated plasma
immunoreactive NT in blood collected from the pancreaticoduodenal vein. Injection of a 1,000 mOsm sodium
chloride solution had a slightly lesser and delayed effect
compared with oleic acid, but a greater effect than 0.1
N hydrochloric acid in isotonic saline solution. Injection
of an amino acid solution (10% Travasol), 300 mOsm
glucose solution, or pure corn oil had no effect. These
results demonstrate that intraduodenal oleic acid is a
potent stimulus for the release of NT from the duodenum into the hepatic-portal circulation of chickens.
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INTRODUCTION

in the intestinal tract (Carraway and Leeman, 1976a)
and the biologically active COOH-terminus of the peptide is highly conserved (Carraway et al., 1982).
Mammalian intestinal NT is localized in enteroendocrine cells, called N cells, which are found scattered
in the mucosal layer of the jejunum. There are a few
N cells in the ileum, but they are very scarce in the
duodenum (Helmstaedter et al., 1977a; Sundler et al.,
1977a). Near the base of the N cell in close proximity to
capillaries are granules that release NT into the hepaticportal circulation (Helmstaedter et al., 1977b; Sundler
et al., 1977b) upon ingestion of a meal (Mashford et al.,
1978; Hammer et al., 1982; Shaw and Buchanan, 1983).
Relative to other digesta, lipids are the most potent in
stimulating immunoreactive NT (iNT) release (Rosell
and Rökaeus, 1979; Ferris et al., 1981; Go and Demol,
1981; Flaten and Hanssen, 1982). Consumption of alcohol and coffee by humans (Mashford et al., 1978),
or perfusion of rat intestine with amino acids, glucose,
hypertonic saline, acidified saline, bile salt, and diluted
bile, has had little or no effect on NT release (Ferris et
al., 1981). In addition to intact NT (i.e., NT1–13), NT
fragments such as NT1–8 and NT1–11 are also released
or are formed as metabolites from NT1–13 in response

Neurotensin (NT) is a tridecapeptide originally isolated from extracts of bovine hypothalami (Carraway
and Leeman, 1973) and gastrointestinal tracts (Kitabgi
et al., 1976; Carraway et al., 1978). The amino acid
sequence is the same from both sources: pGlu-Leu-TyrGlu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH (Carraway and Leeman, 1975; Carraway et al., 1978). The
presence of NT has also been demonstrated in the gastrointestinal tract of several other mammalian species
including humans (Helmstaedter et al., 1977a; Sundler
et al., 1977a; Draviam et al., 1990), rats (Carraway and
Leeman, 1976a; Iwasaki et al., 1980), and dogs (Orci
et al., 1976; Doyle et al., 1985). Neurotensin has since
been immunochemically identified in brain and gut tissues representative of all vertebrate classes and some
invertebrates (Carraway et al., 1982). In all species examined, the majority of the total NT content is found
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to lipids in the intestinal lumen (Ferris et al., 1985a;
Draviam et al., 1990).
Using an RIA specific for bovine NT, Carraway and
Bhatnagar (1980) have isolated and purified NT from
chicken intestinal tracts and have demonstrated its
amino acid sequence to be identical to bovine NT except for the substitution of His3, Val4, and Ala7. Most
published research on intestinal NT has been based on
mammals; very few studies have used birds (Komori
et al., 1986; Denac and Scharrer, 1987; Rawson et al.,
1990; DeGolier et al., 1997; Gui et al., 2000). However,
there is more NT in the avian gut than in the mammalian gut (Carraway et al., 1982). The concentration of
iNT in extracts of intestines measured using the most
specific COOH-terminus directed antiserum, HC-8,
gave measurements in chickens that were 10-fold higher
than corresponding values for mammals. Also, in contrast to mammals, chicken N cells are distributed along
the entire intestinal tract and are particularly numerous in the pylorus, the duodenal region that adjoins the
gizzard. Avian N cells are also found in the colon, but
are rare in the ceca and not present in the proventriculus or pancreas (Sundler et al., 1977b).
Based upon these unique aspects of avian NT, our
objectives were to 1) determine the NT plasma levels
from portal and peripheral sources in fed and fasted
chickens and 2) inject isolated segments of the avian
duodenum with nutrients to determine which components of a meal effectively release iNT into the circulation.

MATERIALS AND METHODS
Birds
Single Comb White Leghorn hens, 10 to 18 wk of
age, were used in this study. Body weights ranged from
0.9 to 1.4 kg. The hens were housed in individual wire
cages in environmentally controlled rooms maintained
at 25°C. The RH was kept between 40 and 50%, and
photoperiod was controlled to provide 14 h of light
from 0900 to 2300 h. All birds had ad libitum access to
water and a diet (all mash breeder ration: 16% protein,
4.5% crude fiber, 3.9% crude fat, 2,874 kcal/kg of ME,
2.7% calcium, and 0.8% phosphorus) prepared by the
Animal Science Department of the University of Minnesota. All procedures were in accord with the policies
of the University of Minnesota Committee on Animal
Laboratory Care.

Surgical Procedures
Hens were fasted overnight to avoid meal-induced increases in plasma levels of NT. They were anesthetized
with 40 mg/kg of sodium pentobarbital (Sqibb-Marson,
Cherry Hill, NJ) injected via the basilic vein. Abdominal feathers were plucked, and the skin was sterilized
with alcohol. A 3-cm incision was made in the abdominal wall 1 cm below the left lateral notch of the sternum
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and 1 cm to the right of the linea alba. The skin and
muscles layers were retracted to expose the duodenal
loop, which was lifted out of the abdominal cavity for
the duration of the experiment. Any apparent ingesta
in the duodenum was gently massaged out of the duodenum into the ileum. The duodenal segment was then
isolated by tying ligatures around the duodenum distal
to the pylorus and proximal to the insertion of the pancreatic ducts. Care was taken to effectively close the
lumen without transecting the gut.
The duodenal loop was then displaced laterally exposing its dorsal surface and the pancreaticoduodenal
(PD) vein. The PD vein was cannulated with an intravenous catheter (24 gauge × 1.9 cm; Critikon, Tampa,
FL), sutured in place, and a sample of blood (3 mL) was
drawn as a control (pretreatment) sample. Heparinized
(1%) saline was injected into the venous catheter to
prevent clotting. The chickens remained anesthetized
throughout the entire experiment, and body temperature was kept constant with a heating pad.

Treatment
The duodenal segment was then injected with 2.5
mL of one of the following test solutions, which represent a typical digestive or secretory constituent in
the duodenum: (1) 0.1 N hydrochloric acid in isotonic
saline solution, (2) an amino acid solution (10% Travasol, Baxter Healthcare Corporation, Deerfield, IL), (3)
1,000 mOsM sodium chloride solution (to mimic the
osmolarity of the 0.1 N HCl solution), (4) 300 mOsM
glucose solution, (5) pure corn oil (Mazola, Englewood
Cliffs, NJ), and (6) a micellar solution of oleic acid
composed 0.45 g of taurodeoxycholate sodium salt (Sigma-Aldrich, St, Louis, MO) in 100 mL of physiological
saline with 0.1 mL of oleic acid (Sigma-Aldrich, St.
Louis, MO). Oleic acid (C18H3402) was used as the lipid
constituent because it is probably the most common
fatty acid occurring in natural fats (Mayes, 1988). All
solutions introduced into the duodenum were previously warmed to the body temperature of chickens (41°C)
in a water bath.
Posttreatment blood samples (3 mL) were collected
at 30 and 60 min after injection of a nutrient into the
duodenum. All blood samples were collected in prechilled tubes (Corning Glass Works, Corning, NY) containing 50 µL of EDTA (Sigma-Aldrich, St. Louis, MO)
at a concentration of 60 mg/mL and adjusted to pH
7, and 3 µL of 0-phenanthroline (Sigma-Aldrich) solubilized in dimethylsulfoxide to a concentration of 0.3
M. Samples were then centrifuged, and the plasma was
removed and frozen at −70°C until assayed.
In a separate group of chickens, portal and peripheral
plasma samples from the wing vein or the PD vein were
collected and treated as described previously. To obtain
preprandial or fasting plasma levels of NT, chickens
were starved for 16 h before sampling. For postprandial
or fed plasma levels of NT, chickens were allowed to eat
for ad libitum 2 h before sample collection.
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NT Assays

Table 1. Immunoreactive NT (fmol/mL) in peripheral and portal plasma collected from fed and fasted chickens1

Radioimmunoassays for chicken NT (Carraway and
Leeman, 1976b) using 125I-labeled NT and multiple
region-specific rabbit antisera primarily directed toward the COOH-terminal region (Carraway and Leeman, 1975) were employed. Several substances in plasma, however, cross-react with region-specific antisera.
Thus, samples were first isolated using HPLC and then
subjected to RIA for several region-specific antisera
(Carraway et al., 1980).

iNT in Intestinal Extracts and Plasma
Immunoreactive NT is present along the entire
length of the small intestine of chickens (Carraway and
Bhatnagar, 1980) and represents a storehouse of NT in
the tissue. Some of that NT is normally released into
the circulation and is present as iNT in the plasma
(Ferris et al., 1981). Because avian NT was assayed
from hepatic-portal plasma, it was first necessary to
determine how much iNT was present in the plasma
before the introduction of oleic acid into the isolated
intestinal segments. Thus, a 10-mg sample of intestinal
mucosa taken from the proximal 10 cm of the chicken
ileum and 6 mL of hepatic-portal plasma were taken
before, and 30 min after, oleic acid perfusion. These
samples were extracted with acid/acetone and applied
to reverse-phase HPLC (Carraway and Leeman, 1976b;
Carraway et al., 1980).

Statistical Analysis
Repeated measures ANOVA (SAS Institute, 1992)
were used to determine if any significant differences
existed between the levels of iNT released into the
hepatic-portal circulation and the time following the
injections of the different test solutions into the duodenum. Analysis of variance was also used to determine
if portal and peripheral plasma levels of NT collected
from fed and fasted birds were significantly different
from each other. These differences were considered significant at P < 0.05.

RESULTS
Plasma Levels of NT
Hepatic portal plasma levels of NT were significantly
higher than peripheral plasma levels of NT (Table 1).
Thus, the majority of NT released from the gut is broken down in its first pass through the liver. Hepaticportal plasma levels of NT collected from fed sources
were also significantly higher than portal plasma collected from fasted birds (P < 0.05), indicating that the
direct presence of food in the gut stimulates the release
of NT into the hepatic-portal circulation. The peripheral plasma levels of NT collected from fed and fasted
birds were not significantly different.

Source
Peripheral
Portal

Fed
Fasted
Fed
Fasted

Mean ± SE

n

3.3a
3.0b
3.9a
3.9b

10
10
6
6

8.2
7.8
61.3
44.5

±
±
±
±

a,bMeans
1Data

with different superscripts are different (P ≤ 0.05).
are presented as means ± SEM; n = number of birds sampled.

Immunoreactive NT Profiles
Comparison of iNT profiles obtained during reversephase HPLC (Figure 1) indicates that after 30 min of
retention time, a peak of 2.5 pmol/mL eluted from the
ileum extract (Figure 1A), whereas only a peak of 0.04
pmol/mL eluted from the control plasma in the same
region after 30 min (Figure 1B). Thus, the small intestine contributed very little NT into the portal circulation under basal conditions. The peak from NT,
however, rose from 0.04 to 0.075 pmol/mL in the plasma extracts that were collected following perfusion of
the ileum with oleic acid (Figure 1C). This is almost
a 2-fold increase in iNT concentration, which demonstrates that intraduodenal lipid is a potent stimulus
for the release of NT from the duodenum into hepaticportal circulation.

Release of NT in Response
to Intraluminal Contents
Plasma concentrations of iNT following the injection
of the test solutions into the duodenum were calculated
as a percentage of the pretreatment plasma level in each
bird. Even though chickens were fasted overnight before experiments, the pretreatment plasma levels were
somewhat variable but were not significantly different
from each other. It can be speculated that ingesta retained in the crop or refluxed from the lower intestine
might account for ingesta occurring in the duodenum
of fasted hens and contribute to the release of iNT into
the portal plasma before treatments.
There were significant interactions between the levels
of iNT released by exposure of the duodenal mucosa to
the various treatment solutions and the amount of time
that the solutions were kept in the duodenal segment
(Figure 2). Thirty minutes after injection of oleic acid,
iNT levels were significantly greater (P < 0.05) than
those resulting from injections of amino acids, glucose,
saline, and corn oil, but not HCl. Sixty minutes after
injection of oleic acid, iNT levels were still higher than
saline and were statistically higher than amino acids,
HCl, glucose, and corn oil. Although oleic acid was the
most potent stimulus used, the iNT levels 60 min after injection of hypertonic saline were also statistically
higher (P < 0.05) than amino acids, glucose, and corn
oil. Immunoreactive NT was also elevated 60 min after
HCl injection and was greater than corn oil (P < 0.05).
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any intraduodenal nutrient stimulation. Results from
the RIA in Table 1 indicate NT exists in portal plasma
collected from fasted birds, but at levels that are significantly lower than NT plasma levels from fed birds.
Because all of our birds responded to some degree to
the presence of a nutrient along the gut mucosa, our results are consistent and in agreement with mammalian
studies, which demonstrated that oleic acid is the most
potent nutrient in stimulation of the release of NT into
portal circulation (Rosell and Rökaeus, 1979; Ferris et
al., 1981; Go and Demol, 1981; Flaten and Hanssen,
1982; Walker et al., 1985).
In addition to NT, NT fragments or metabolites of
NT can also be released into the circulation after lipid
infusion (Ferris et al., 1981). Estimating the amount of
NT released in response to a physiologic stimulus such
as intraintestinal oleic acid is complicated by the slow
elimination of NT metabolites from circulation. Aronin
et al. (1982) has shown that a portion of NT1–13 that is
injected intravenously into a rat is rapidly metabolized
to NT1–8 or NT1–11. These NT metabolites have a longer half-life (5 and 9 min, respectively) than the whole
peptide (i.e., NT1–13 t1/2 = 0.55 min). The amount
of NT1–13, its amino terminal fragments (NT1–8 and
NT1–11), and its carboxyl terminal fragments (NT8–13)
can be identified by HPLC and measured by RIA (Ferris et al., 1985b; Draviam et al., 1990). Because we
were measuring NT1–13 and wanted to avoid significant
contamination with NT1–8 and NT1–11, we collected

Figure 1. Comparison of the profiles of immunoreactive neurotensin (NT) obtained during reverse-phase HPLC of (A) an extract of 10
mg of chicken ileum; (B) an extract of 6 mL of control plasma; and (C)
an extract of 6 mL of plasma obtained 30 min after lipid (here, oleic
acid) perfusion into the ileum. The dotted line in panel A represents
the acetonitrile line.

DISCUSSION
The results of this study have demonstrated that
increased levels of iNT are released into the hepaticportal circulation in response to the presence of a micellar solution of oleic acid in contact with the duodenal mucosa. Hypertonic saline and HCl had somewhat
reduced and delayed effects compared with oleic acid,
but their effects were greater than the effect of amino
acids, glucose, and corn oil. The saline test solution
was hypertonic to the glucose solution, suggesting that
osmolarity may be a variable stimulating the release of
NT. However, the amino acid solution was isosmotic to
the saline and yet produced an even smaller response,
indicating that osmolarity is not a factor in NT release.
Our results also indicated that other factors besides
nutrient stimulation may regulate the release of NT in
chickens. The profile of iNT obtained from HPLC (Figure 1) showed that iNT is present in the plasma before

Figure 2. Immunoreactive neurotensin (iNT; fmol/mL) in hepaticportal plasma following injections of amino acids (aa, n = 8), HCl (n
= 7), glucose (gluc, n = 7), hypertonic NaCl (saline, n = 6), oleic acid
(oleic, n = 7), and corn oil (corn, n = 6) into isolated segments of the
duodenum. Data points (means ± SEM) are presented as a percentage
of the pretreatment plasma level (hepatic-portal, fasted) in each bird.
Several interactions occurred between the levels of iNT released into
the hepatic-portal circulation and the time following the injections of
the different test solutions into the duodenum. See the Results section
for individual relationships.
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plasma samples directly from hepatic-portal blood via
the pancreaticoduodenal vein before NT was metabolized in the liver. Ferris et al. (1985b) demonstrated in
rats that there is significantly more NT in the portal
circulation than in the peripheral circulation during
lipid perfusion in the small intestine.
Rosell and Rökaeus (1981), after administering a lipid solution to humans (intravenously), could not detect
any significant change in circulating NT. This prompted
several studies to determine if NT release is dependent
upon direct stimulation of the mucosa of the intestinal
segments containing the N cells. Despite the fact that
the major stores of mammalian NT are in the ileum
(Helmstaedter et al., 1977a; Sundler et al., 1977a), the
selective perfusion of the duodenum and jejunum, and
not the ileum, significantly increased the portal plasma
levels of NT (Fujimura et al., 1989; Kihl et al., 1980;
Read et al., 1984; Walker et al., 1985). Thus, in mammals, the release of NT from the distal gut may not be
due to direct stimulation, but may be dependent upon
a signal from the proximal gut and mediated via a local
nerve or peptide intermediate (Walker et al., 1985; Fujimura et al., 1989). In chickens, it appears that direct
stimulation is responsible for some NT release, but our
conclusions are based only on the response from the
duodenal mucosa. Because N cells are located along
the entire intestine of the chicken (Helmstaedter et al.,
1977a; Sundler et al., 1977a), further study is needed to
determine if the ileum is equally effective in releasing
NT and if the response is dependent upon some sort of
signaling or feedback.
Some mammalian studies indicate that the release of
NT into the circulation is lipid specific. For example,
in primary cultures of canine enteric endocrine cells,
the release of NT-like immunity (NTLI) was demonstrated to be specific for long-chain, unsaturated fatty
acids, and stereospecific for cis isomers (Barber et al.,
1991). Perfusion of rat intestine with fatty acids with 4
or more carbons and alcohols with 2 or more carbons
significantly elevated NTLI plasma levels (Ferris et al.,
1985a). In the present study, corn oil, which is composed of a mixture of several glycerides of fatty acids
and unsaturated fatty acids, was the least stimulatory
in releasing iNT (Figure 2). Even though oleic acid is
present in corn oil, the percent is variable (19 to 49%,
O’Neil, 2006) and it was not administered with bile
salts or as a micellar solution. Mixing the corn oil with
bile, exposing it to a different segment of the gut, or
using a bird species acclimated to a higher fat content
in their diet may yield different results.
In contrast to some mammalian studies (Ferris et al.,
1981; Fujimura et al., 1989), our results indicate that
hypertonic saline is an effective stimulus in releasing
iNT into the hepatic-portal plasma. The test solutions
used in this experiment are similar to the chemical nature of digesta in the duodenum and can depress gastric motility; this is known as the enterogastric reflex.
When hydrochloric acid, hypertonic saline, and lipid
solutions were injected into the turkey duodenum, gas-

tric motility was inhibited (Duke and Evanson, 1972;
Duke et al., 1973). The onset of inhibition after the acid
injection was within seconds, but the onset of inhibition
following lipid or saline injection occurred 4 to 6 min
later. Because lipids and hypertonic saline release NT,
the enterogastric inhibitory effects of lipids and hypertonic saline in chickens may be mediated humorally by
NT. Evidence in support of this mechanism is that NT
has been shown to inhibit gastric motility in chickens
(DeGolier et al., 1997).
In conclusion, our data suggest that the N cells in
the chicken intestine appear to function as a production, intracellular storage, and release site for NT into
the portal circulation. The elevation of plasma iNT following direct stimulation by a micellar solution of oleic
acid demonstrates that NT has a physiological role in
avian digestion as it does in mammals. The localization
of NT in the gut as well as in the brain make it a member of a rapidly growing list of brain-gut peptides (e.g.,
gastrin, cholecystokinin, motilin, vasoactiveintestinal
peptide, substance P, somatostatin, and gastrin-releasing peptide). When localized in brain or gut neurons,
these peptides are known to be synaptic mediators or
neurotransmitters; when localized in the gut, they act
as gastrointestinal hormones and employ their effects in
an endocrine or paracrine fashion.
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